Literature DB >> 32601984

Acute Valproate Exposure Induces Sex-Specific Changes in Steroid Hormone Metabolism in the Cerebral Cortex of Juvenile Mice.

Sung-Hee Cho1, Jung Hoon Chai2, Sung-Youn Chang3, Soon Ae Kim4.   

Abstract

Valproic acid (VPA), an antiepileptic and mood stabilizer, modulates neurotransmission and gene expression by inhibiting histone deacetylase activity. It is reported that VPA may affects the steroid hormone level. In this study, VPA-induced acute metabolic alterations were investigated using liquid chromatography-tandem mass spectrometry in prepubertal mice brain. In VPA-treated (400 mg/kg in saline solution, intraperitoneal) mice, cortisol levels were increased (female: P < 0.004, male: P < 0.003) and 17β-estradiol levels were decreased (Both P < 0.03). Furthermore, in the VPA-treated male mice, dihydrotestosterone levels were increased (P < 0.02) and testosterone were decreased (P < 0.002). The 4-hydroxylase activity was upregulated in the female VPA-treated mice (P < 0.01) and the 5α-reductase activity was increased in the male VPA-treated mice (P < 0.003). These results indicate sex specific differences in VPA-induced steroid metabolism in the brain cortex.

Entities:  

Keywords:  Metabolic alteration; Sex differences; Steroid hormone; Valproic acid (VPA)

Mesh:

Substances:

Year:  2020        PMID: 32601984     DOI: 10.1007/s11064-020-03065-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  30 in total

Review 1.  Reproductive and metabolic abnormalities in women taking valproate for bipolar disorder: a meta-analysis.

Authors:  Lin Zhang; Hua Li; Shaoping Li; Xiaoyi Zou
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2016-04-30       Impact factor: 2.435

2.  GABA as an inhibitory neurotransmitter in human cerebral cortex.

Authors:  D A McCormick
Journal:  J Neurophysiol       Date:  1989-11       Impact factor: 2.714

3.  Effects of DI-n-propylacetate, and anticonvulsive compound, on GABA metabolism.

Authors:  Y Godin; L Heiner; J Mark; P Mandel
Journal:  J Neurochem       Date:  1969-06       Impact factor: 5.372

4.  GABA regulates corticotropin releasing hormone levels in the paraventricular nucleus of the hypothalamus in newborn mice.

Authors:  Matthew S Stratton; Brian T Searcy; Stuart A Tobet
Journal:  Physiol Behav       Date:  2011-01-12

5.  Inactivation of beef brain alpha-ketoglutarate dehydrogenase complex by valproic acid and valproic acid metabolites. Possible mechanism of anticonvulsant and toxic actions.

Authors:  A S Luder; J K Parks; F Frerman; W D Parker
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

6.  Histone deacetylase 1 (HDAC1) participates in the down-regulation of corticotropin releasing hormone gene (crh) expression.

Authors:  Lydia Miller; Chad D Foradori; Avin S Lalmansingh; Dharmendra Sharma; Robert J Handa; Rosalie M Uht
Journal:  Physiol Behav       Date:  2011-04-01

Review 7.  Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain.

Authors:  W Löscher
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

8.  Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats.

Authors:  Marzia Pesaresi; Omar Maschi; Silvia Giatti; Luis Miguel Garcia-Segura; Donatella Caruso; Roberto Cosimo Melcangi
Journal:  Horm Behav       Date:  2009-05-05       Impact factor: 3.587

9.  Effects of antiepileptic drugs on reproductive endocrine function, sexual function and sperm parameters in Chinese Han men with epilepsy.

Authors:  Xu Xiaotian; Zhang Hengzhong; Xu Yao; Zhao Zhipan; Xu Daoliang; Wu Yumei
Journal:  J Clin Neurosci       Date:  2013-08-09       Impact factor: 1.961

10.  The anti-epileptic drug valproic acid (VPA) inhibits steroidogenesis in bovine theca and granulosa cells in vitro.

Authors:  Claire Glister; Leanne Satchell; Anthony E Michael; Andrew B Bicknell; Philip G Knight
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.